{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T22:14:24Z","timestamp":1780352064866,"version":"3.54.1"},"reference-count":29,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,7,28]],"date-time":"2006-07-28T00:00:00Z","timestamp":1154044800000},"content-version":"vor","delay-in-days":4195,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pigment Cell Research"],"published-print":{"date-parts":[[1995,2]]},"abstract":"<jats:p>Patients with vitiligo have circulating antibodies directed in part to pigment cell antigens with MWs of approximately 90, 75, and 40\u201045 kDs. These antigens are denominated VIT 90, VIT 75, and VIT 40, respectively. To further characterize these \u201cvitiligo\u201d antigens, we examined their relation to antigens defined by a panel of 25 monoclonal antibodies (moab) to pigment cell antigens. We found by immunoprecipitation and SDS\u2010PAGE analysis of <jats:sup>125<\/jats:sup>I labelled, detergent soluble, human melanocyte macromolecules, that 24 (83%) of 29 patients with vitiligo had antibodies to one or more vitiligo antigens vs. 2 (7%) of 28 control individuals. Seventeen of the 25 moabs did not react with any labelled antigen in the same lysate. Of the remaining eight moabs, only four precipitated an antigen that co\u2010migrated with one of the vitiligo antigens. Moab TA99, HMSA\u20105, and TMH\u20101 (all directed to the 75 kD tyrosinase\u2010related protein [TRP1]) co\u2010migrated with VIT 75. Moab W6\/32 (directed to class I HLA antigen) co\u2010migrated with VIT 40. Immunodepletion studies with vitiligo antibodies selectively depleted the antigen defined by W6\/32 but not the antigen defined by TA99 and HMSA\u20105, indicating that VIT 75 was not the 75 kD tyrosinase\u2010related protein. The vitiligo antigens were easily labelled by the lactoperoxidase technique but poorly labelled with <jats:sup>35<\/jats:sup>S\u2010methionine, suggesting they are expressed on the cell surface.<\/jats:p><jats:p>These studies indicate that VIT 90 and VIT 75 differ from antigens defined by currently available moabs to pigment cell antigens. VIT 40 appears to share a cross\u2010reactive epitope, or be tightly bound to, class I HLA antigen.<\/jats:p>","DOI":"10.1111\/j.1600-0749.1995.tb00774.x","type":"journal-article","created":{"date-parts":[[2006,7,29]],"date-time":"2006-07-29T16:10:06Z","timestamp":1154189406000},"page":"53-59","source":"Crossref","is-referenced-by-count":54,"title":["Characterization of Vitiligo Antigens"],"prefix":"10.1111","volume":"8","author":[{"given":"JIAN","family":"CUI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUKO","family":"ARITA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JEAN\u2010CLAUDE","family":"BYSTRYN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,7,28]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.158.1.246"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12522891"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1985.tb01532.x"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(86)70260-0"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12492607"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12555773"},{"key":"e_1_2_1_8_1","first-page":"333","article-title":"On the subject of serum antibodies to melanocytes in vitiligo","volume":"84","author":"Moellman G.E.","year":"1985","journal-title":"J. Invest. Dermatol."},{"key":"e_1_2_1_9_1","first-page":"783","article-title":"Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement\u2010mediated damage and antibody dependent cellular cytotoxicity ADCC. J. Invest","volume":"90","author":"Norris D.A.","year":"1988","journal-title":"Dermatol."},{"key":"e_1_2_1_10_1","first-page":"113","article-title":"Enhanced susceptibility of melanocytes to different immunologic effector mechanisms in vitro: potential mechanisms for postinflammatory hypopigmentation and vitiligo. Pigment Cell Res","volume":"1","author":"Norris D.A.","year":"1988","journal-title":"[Suppl.]"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12476636"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910470221"},{"key":"e_1_2_1_13_1","first-page":"4401","article-title":"Surface antigens of melanoma and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression cultured cells and tissues","volume":"45","author":"Real F.X.","year":"1985","journal-title":"Cancer Res."},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12460906"},{"key":"e_1_2_1_15_1","first-page":"2904","article-title":"Development and characterization of a mouse monoclonal antibody, MoAb HMSA\u20101, against a melanosomal fraction of human malignant melanoma","volume":"46","author":"Akutsu Y.","year":"1986","journal-title":"Cancer Res."},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1993.8"},{"key":"e_1_2_1_17_1","first-page":"6840","article-title":"Flow cytometric determination of the frequency and heterogeneity of expression of human melanoma\u2010associated antigens","volume":"49","author":"Berd D.","year":"1989","journal-title":"Cancer Res."},{"key":"e_1_2_1_18_1","first-page":"5091","article-title":"Antigenic profile of tumor progression stages in human melanocytic nev and melanomas","volume":"49","author":"Elder D.E.","year":"1989","journal-title":"Cancer Res."},{"key":"e_1_2_1_19_1","first-page":"4557","article-title":"Biosynthesis, glycosylation and intracellular processing of the neuroglandular antigen, a human melanoma\u2010associated antigen","volume":"50","author":"Dixon W.T.","year":"1990","journal-title":"Cancer Res."},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.4.2183"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/80.14.1154"},{"key":"e_1_2_1_22_1","first-page":"195","article-title":"Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes","volume":"123","author":"Gown A.M.","year":"1986","journal-title":"Am. J. Pathol."},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(78)90296-9"},{"key":"e_1_2_1_24_1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4049\/jimmunol.125.1.293","article-title":"Two populations of Ia\u2014like molecules on human B cell line","volume":"125","author":"Lampson L.A.","year":"1980","journal-title":"J. Immunol."},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.155.4.1133"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/90.4.385"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.161.2.366"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12277121"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.79.6.2018"},{"key":"e_1_2_1_30_1","first-page":"2310","article-title":"Identification and purification of a 75 kD dalton cell\u2010surface human melanoma associated antigen","volume":"42","author":"Heaney\u2010Kieras J.","year":"1982","journal-title":"Cancer Res"}],"container-title":["Pigment Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0749.1995.tb00774.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0749.1995.tb00774.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T19:06:03Z","timestamp":1698260763000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0749.1995.tb00774.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,2]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,2]]}},"alternative-id":["10.1111\/j.1600-0749.1995.tb00774.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0749.1995.tb00774.x","archive":["Portico"],"relation":{},"ISSN":["0893-5785","1600-0749"],"issn-type":[{"value":"0893-5785","type":"print"},{"value":"1600-0749","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,2]]}}}